about
Pneumonia, thrombosis and vascular diseaseIntramyocardial hemorrhage: an enigma for cardiac MRI?Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia?Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin.Patients with microvascular obstruction after primary percutaneous coronary intervention show a gp91phox (NOX2) mediated persistent oxidative stress after reperfusion.Total adiponectin is inversely associated with platelet activation and CHA₂DS₂-VASc score in anticoagulated patients with atrial fibrillation.NPR-C: a component of the natriuretic peptide family with implications in human diseases.Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides.Statins as antithrombotic drugs.Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure: implications for novel therapeutic strategies.C2238 atrial natriuretic peptide molecular variant is associated with endothelial damage and dysfunction through natriuretic peptide receptor C signaling.Aspirin reload before elective percutaneous coronary intervention: impact on serum thromboxane b2 and myocardial reperfusion indexes.Low-grade endotoxemia and clotting activation in the early phase of pneumonia.Relation of Cardiac Complications in the Early Phase of Community-Acquired Pneumonia to Long-Term Mortality and Cardiovascular Events.Platelet activation is associated with myocardial infarction in patients with pneumonia.Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia.Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia.Allergic Inflammation Is Associated With Coronary Instability and a Worse Clinical Outcome After Acute Myocardial Infarction.Relationship between carotid intima-media thickness and non valvular atrial fibrillation type.Primary aldosteronism with concurrent primary hyperparathyroidism in a patient with arrhythmic disorders.Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role.Aminoterminal natriuretic peptides and cardiovascular risk in an Italian male adult cohort.Response to Letter Regarding Article, "Allergic Inflammation Is Associated With Coronary Instability and a Worse Clinical Outcome After Acute Myocardial Infarction".Hospitalization for pneumonia and risk of cardiovascular disease.Permanent polymer of drug eluting stents increases eosinophil cationic protein levels following percutaneous coronary intervention independently of C-reactive protein.Atrogin-1 Pathway Activation in Cushing Syndrome Cardiomyopathy.Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production.ReplyReplyReplyDifferent behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillationNT-proANP/ANP is a Determinant of Vascular Damage in HumansEpicardial Fat Thickness and Primary Aldosteronism
P50
Q26853685-0B233BE3-945A-4DAD-BA92-5AA9B3986DEDQ28082737-37E8A531-27D3-4CB3-9A7E-938C053F0421Q33687757-9C287AE5-30BE-458F-9675-0770F33E72B8Q35088200-3B81B934-3236-4155-B3E7-A2E48AEED709Q37291936-9FB877ED-C910-42C5-83A8-C3FA77E0C0DCQ37639726-5F15387C-A076-4522-BD6A-EEFF67A638FEQ37766468-C3ABEB56-A523-445E-9F86-646E75B48842Q37914058-C5AE5E1F-2E81-4FE9-82FC-C72E10D75E9CQ38074147-86DE4726-BB2C-47F9-9CD0-E87164233D78Q38092606-DE504884-312C-406D-846D-D152C97E8DEEQ38316737-F40882CA-6F6C-436E-8327-047919CB75B7Q38426111-E7BF97D7-A273-4EE9-8E22-E6F81324FAF3Q38930881-16E6BFED-B0AB-4C89-B435-0744CB8F183FQ38930892-CA612DA0-BB2A-4D3C-ADD0-79BE0549F9FBQ38930897-7947B59A-992D-46B4-8B2D-C67D89319CF1Q39187283-87505ED4-3EF8-47B8-BB2E-65BBB01BB6CBQ39562368-68B2F4DE-2052-41A4-AD4F-B918C1E8719DQ41513440-387F9238-7DDB-4E47-B025-7C2923ABCB2FQ41565690-5351F179-A1F7-4B69-943D-7C43346AEBA1Q43978245-5A165A9E-CB07-4AA2-991B-26199915A266Q44419221-9B173539-6B8D-4D23-9229-4EF459D192A2Q48937165-1372915D-46E4-413F-980D-9BD9382B84FDQ51584913-8DA71B1F-AA46-4715-818C-32F0003A30E2Q51634101-A2EA0718-2E86-43E2-AB23-AD97CA6E0E24Q51678503-C5613ACD-4105-4E77-9BB3-128490B468F6Q53210302-D4E5E0E5-CA22-488A-A0EC-E202DACB8585Q55000599-671FFBC9-C681-4E78-8E0F-2E7F846BFA5DQ58420693-1EBDB289-81C4-48E6-9836-CD1ECD78BE43Q58420697-CD812A50-E706-4CEF-9F30-24394DF6523EQ58420699-89DEC428-E11C-43F4-8ADE-B31D78012244Q58420859-7F647435-EACB-4EFC-8110-7945BD1FC3B8Q59624975-6C5D5ADA-E713-4F56-9230-028FE91B5952Q87473178-A017E04B-6BB6-44FC-B197-7DCBC880E002
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Camilla Calvieri
@ast
Camilla Calvieri
@en
Camilla Calvieri
@es
Camilla Calvieri
@nl
type
label
Camilla Calvieri
@ast
Camilla Calvieri
@en
Camilla Calvieri
@es
Camilla Calvieri
@nl
prefLabel
Camilla Calvieri
@ast
Camilla Calvieri
@en
Camilla Calvieri
@es
Camilla Calvieri
@nl
P106
P1153
24079875100
P21
P31
P496
0000-0001-6548-3400